CGIM
RMD icon

Cannon Global Investment Management’s ResMed RMD Stock Holding History

Cannon Global Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,000
Closed -$2.4M – 30
2022
Q3 		$2.4M Buy
11,000
+4,000
+57% +$910K 3.88% 10
2022
Q2 		$1.47M Buy
7,000
+5,000
+250% +$1.06M 26.37% 2
2022
Q1 		$485K Buy
+2,000
New +$484K 0.35% 62

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Cannon Global Investment Management's RMD Position: Q4 2022 in Review

Cannon Global Investment Management sold out of ResMed (RMD) in Q4 2022, closing a stake of 11,000 shares — an estimated $2.4M sold.

Cannon Global Investment Management first reported a position in RMD in Q1 2022 and held it in 3 quarters. The position peaked at $2.4M in Q3 2022. 731 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

  • Cannon Global Investment Management reported no remaining ResMed position as of Q4 2022 after selling out during the quarter.
  • Cannon Global Investment Management sold 11,000 ResMed shares in Q4 2022, an estimated $2.4M.
  • Cannon Global Investment Management first reported a position in ResMed in Q1 2022 and held it in 3 quarters.
  • Cannon Global Investment Management's ResMed position peaked at $2.4M in Q3 2022.
  • 731 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on Cannon Global Investment Management's 13F filing for Q4 2022, filed 8 Feb 2023.